| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_da512e94ab6e23c58dc0f3e871319512
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1eaa06d9a0cd593bf7bb48e1ab6f9161
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_40b595f67aca333e1ddb5db8f356de31
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d9208ad4179e3c0d9125d342f1be9e46
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_23d7114761126a24b0450f59dba42bc3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c1f628fa19f4043fb84685d00eb764e5 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01N1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-19
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0644 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-19
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-078 |
| filingDate |
2012-06-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_de563686918925d2dad59141a906d170
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3cc221ad412baae3205bd7877dd0a11d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5ceb82bef8ca52f3cbffb27afa68d21f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_02690ad4a2d2666a81354370d587be79
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2c82f9b82d1261d28749c13420e9377a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8407780ee0b755b729eb5dae452b083f |
| publicationDate |
2013-03-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2013059287-A1 |
| titleOfInvention |
Prolonging Survival of Platelets Using CMP-Sialic Acid, UDP-Galactose or Both |
| abstract |
The present invention provides modified platelets having a reduced platelet clearance and methods for reducing platelet clearance. Also provided are compositions for the preservation of platelets. The invention also provides methods for making a pharmaceutical composition containing the modified platelets and for administering the pharmaceutical composition to a mammal to mediate hemostasis. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10897891-B2 |
| priorityDate |
2004-10-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |